Related Experiment Video
Updated: Jul 8, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Overestimation and underestimation of cardiovascular risk in clinical practice: usefulness of risk estimation charts
Athanasios Pipilis1, Sotirios Kaliambakos, Christos Xenodochidis
11st Cardiology Clinic, "Hygeia" Diagnostic and Therapeutic Centre, Athens, Greece. a.pipilis@hygeia.gr
Insights
Clinical judgment aligns with cardiovascular risk guidelines for extreme cases but falters with intermediate risks. Utilizing risk charts can enhance the objectivity of preventive cardiovascular care.
Area of Science:
- Cardiology
- Preventive Medicine
- Clinical Decision Making
Background:
- Cardiovascular risk charts are crucial for managing asymptomatic individuals.
- Physicians often make management decisions without consulting these risk assessment tools.
- This study evaluated the accuracy of clinical judgment against established guidelines.
Purpose of the Study:
- To quantify the extent of cardiovascular risk overestimation and underestimation in clinical practice.
- To compare physician-based risk assessment with European Society of Cardiology guidelines.
- To identify discrepancies in managing intermediate cardiovascular risk cases.
Main Methods:
- Thirty primary care physicians assessed seven anonymized patient cases with varying cardiovascular risk profiles.
- Physicians determined the need for hypolipidaemic therapy for each case.
- Responses were compared against recommendations from European cardiovascular prevention guidelines and risk charts.
Main Results:
- Overall agreement with guidelines was 70%, with absolute agreement in very low and very high-risk cases.
- Agreement significantly decreased in intermediate-risk cases, particularly those with cholesterol levels between 200-240 mg/dL (40% agreement).
- Both overestimation and underestimation of cardiovascular risk were observed in intermediate cases.
Conclusions:
- Physician judgment aligns with guidelines for clear-cut low or high cardiovascular risk.
- Intermediate cardiovascular risk cases show significant variability, leading to inappropriate hypolipidaemic treatment prescriptions or missed therapeutic opportunities.
- Implementing cardiovascular risk charts in practice can promote more objective and evidence-based preventive strategies.
Introduction:
Charts for the estimation of cardiovascular risk contribute greatly to clinical decision making in the management of asymptomatic individuals. However, most decisions are taken without consulting the charts. The aim of our study was to record the degree of overestimation or underestimation of cardiovascular risk in everyday clinical practice.
Methods:
Seven cases of asymptomatic individuals at different levels of cardiovascular risk as a result of different combinations of risk factors (one at very low, one at very high and five at intermediate risk) were presented in random order to 30 doctors who deal with primary prevention consultations in their daily clinical practice. They were asked if hypolipidaemic therapy was needed and their answers were compared with the recommended management of the current European guidelines on prevention using the risk charts of the European Society of Cardiology.
Results:
The mean percentage of agreement was 70%. In the two extreme cases agreement with the guidelines was absolute, but in the intermediate cases it varied widely. Particularly in those cases with cholesterol level 200-240 mg/dl it was just 40%, due either to overestimation or to underestimation of the risk.
Conclusion:
In the cases of obviously low or obviously high risk, clinical judgement is in accordance with the guidelines. However, in cases of intermediate risk there is either overestimation of risk with non-indicated prescription of hypolipidaemic treatment, or underestimation of risk with no administration of indicated therapy. The use of risk charts in clinical practice may provide substantial help towards a more objective practice of prevention.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Errors occurring during blood pressure monitoring
Several factors...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Relative Risk
Pre-Procedural Guidelines for Assessing Blood Pressure
Hazard Ratio
For example, in a clinical trial evaluating a...